Mozambique vs Somalia: Average cost of multi drug-resistant tuberculosis treatment
Mozambique
1,250 constant 2022 US$
in 2024
Somalia
1,178 constant 2022 US$
in 2021
Mozambique rank
37th
Somalia rank
40th
Average cost of multi drug-resistant tuberculosis treatment over time
- Mozambique
- Somalia
How they compare
Mozambique currently reports 1,250 constant 2022 US$ against 1,178 constant 2022 US$ in Somalia, a difference of 72 constant 2022 US$.
That makes Mozambique's figure about 1.1 times Somalia's.
Across all 5 years both countries report, Mozambique has been ahead every year.
Mozambique ranks 37th and Somalia ranks 40th of 92 countries.
Mozambique has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mozambique | Somalia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3,095 constant 2022 US$ | 1,490 constant 2022 US$ | 1,605 constant 2022 US$ | Mozambique |
| 2020s | 3,038 constant 2022 US$ | 1,340 constant 2022 US$ | 1,698 constant 2022 US$ | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Mozambique or Somalia?
- Mozambique, at 1,250 constant 2022 US$ against 1,178 constant 2022 US$ in Somalia as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Mozambique and Somalia?
- 72 constant 2022 US$, with Mozambique ahead.
- How many years of comparable data are there for Mozambique and Somalia?
- 5 years are reported by both, from 2017 to 2021.
- How do Mozambique and Somalia rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Mozambique ranks 37th and Somalia ranks 40th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.